Document is current
Any future updates will be listed below
-
Authors
Gold, Lukas
Klambauer, Konstantin
Dascalescu, Christian
Klinge, Luca
Winkelmann, Michael
Mansour, Nabeel
Mehrens, Dirk
Ricke, Jens
von Bergwelt-Baildon, Michael
Di Gioia, Dorit
Lindner, Lars H.
Kunz, Wolfgang G.
-
Funding
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
- License Information
-
More Information
Article History
Received: 12 July 2025
Accepted: 20 February 2026
First Online: 26 February 2026
Declarations
:
: The retrospective study was approved by the LMU Munich Institutional Review Board (LMU Ethics Committee, project number 22–0321). Because all patients had previously consented to the use of their data within the study registry, the requirement for additional informed consent was waived.
: Not applicable.
: M.v.B.-B. received research funding and honoraria from Novartis, Kite Pharma, Miltenyi Biotec, Mologen, MSD, Astellas, and Roche. W.G.K. served as advisor to Bristol Myers Squibb, Boehringer Ingelheim, mintMedical and Need, Inc.. The remaining authors declare no competing financial interests.
